This topic contains a solution. Click here to go to the answer

Author Question: The nurse is caring for a cardiac client who has developed a lupus erythematosus-like syndrome. The ... (Read 13 times)

Bernana

  • Hero Member
  • *****
  • Posts: 530
The nurse is caring for a cardiac client who has developed a lupus erythematosus-like syndrome. The nurse anticipates that the client is taking:
 
  a. quinidine. c. lidocaine.
  b. procainamide. d. dopamine.

Question 2

When monitoring a client taking quinidine, the nurse assesses for manifestations of:
 
  a. tinnitus and vertigo. c. bradycardia and hypotension.
  b. hypertension and tachycardia. d. constipation and nausea.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

sokh

  • Sr. Member
  • ****
  • Posts: 357
Answer to Question 1

ANS: B

Feedback
A Incorrect: This is not an adverse effect of quinidine.
B Correct: This is an adverse effect of procainamide.
C Incorrect: This is not an adverse effect of lidocaine.
D Incorrect: This is not an adverse effect of dopamine.

Answer to Question 2

ANS: A

Feedback
A Correct: These are manifestations of cinchonism, a hypersensitivity syndrome of quinidine.
B Incorrect: Quinidine may cause hypotension.
C Incorrect: Quinidine may cause tachycardia.
D Incorrect: Quinidine may cause diarrhea.




Bernana

  • Member
  • Posts: 530
Reply 2 on: Jul 24, 2018
Wow, this really help


amandanbreshears

  • Member
  • Posts: 320
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

There are approximately 3 million unintended pregnancies in the United States each year.

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

According to the National Institute of Environmental Health Sciences, lung disease is the third leading killer in the United States, responsible for one in seven deaths. It is the leading cause of death among infants under the age of one year.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library